State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3

Siebert, Uwe, Alagoz, Oguzhan, Bayoumi, Ahmed M., Jahn, Beate, Owens, Douglas K., Cohen, David J., Kuntz, Karen M.·2012·Value in Health

DOI 10.1016/j.jval.2012.06.014

Cited by (494)

Items 201–300 of 494

A Microsimulation Model for Evaluating the Effectiveness of Cancer Risk Management for BRCA Pathogenic Variant Carriers: miBRovaCAre
Lara Petelin, Lucinda Hossack, Gillian Mitchell · 2019 · Value in Health
How simulation modeling can support the public health response to the opioid crisis in North America: Setting priorities and assessing value
Nick J Bansback, Carolina Barbosa, Joshua A. Barocas, Ahmed M. Bayoumi, Czarina Navos Behrends, Jag Chhatwal, Lauren E. Cipriano, Phillip Oliver Coffin, Jeremy D. Goldhaber‐Fiebert, Jeffrey S. Hoch et al. · 2020 · International Journal of Drug Policy
Users’ Guide to Medical Decision Analysis
Claudia Caroline Dobler, Gordon Henry Guyatt, Zhen Wang · 2021 · Mayo Clinic Proceedings
Cycle‐network expansion plan in Oslo: Modeling cost‐effectiveness analysis and health equity impact
Admassu Nadew Lamu, Ole Frithjof Norheim, Fredrik Alexander Gregersen, Mathias Barra · 2021 · Health Economics
Cost-utility analysis of percutaneous mitral valve repair in inoperable patients with functional mitral regurgitation in German settings
Oleg Borisenko, Michael Haude, Uta Charlotte Hoppe · 2015 · BMC Cardiovascular Disorders
Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults
T. Sharma · 2020 · Public Health
Benefits and Harms of a Prevention Program for Iodine Deficiency Disorders: Predictions of the Decision-Analytic EUthyroid Model
Monika Schaffner, Nikolai Mühlberger, Annette Conrads‐Frank, Vjollca Qerimi, Gaby Sroczynski, Eftychia G. Koukkou, Betina Heinsbæk Thuesen, Henry Völzke, Wilhelm Oberaigner, Uwe Siebert et al. · 2020 · Thyroid
Available Methods for Benefit-risk Assessment: Lessons for Inflammatory Bowel Disease Drugs
Bénédicte Caron, Ferdinando D’Amico, Vipul Jairath · 2022 · Journal of Crohn s and Colitis
Personalised rehabilitation to improve return to work in patients with persistent spinal pain syndrome type II after spinal cord stimulation implantation: a study protocol for a 12-month randomised controlled trial—the OPERA study
Maarten Moens, Lisa Goudman, Dominique VAN DE VELDE, Lode Godderis, Koen D. Putman, Jonas Callens, Olivia Lavreysen, Dries Ceulemans, Laurence Leysen, Jean‐Pierre Van Buyten et al. · 2022 · Trials
Microsimulation Models on Mental Health: A Critical Review of the Literature
Claire de Oliveira, Maria Ana Matias, Rowena Jacobs · 2023 · Value in Health
Next-generation sequencing in oncology: challenges in economic evaluations
Morgan Ehman, Jesman Punian, Deirdre Weymann, Dean A. Regier · 2024 · Expert Review of Pharmacoeconomics & Outcomes Research
Beyond binary endpoints: modernizing aesthetic trial analytics: Simulation-Based reappraisal of phase 2/3 BoNT-A studies using advanced statistical models
Eqram Rahman, Parinitha Rao, Alexander D Nassif, William Richard Webb, Woffles T. L. Wu, JEAN D. A. CARRUTHERS · 2025 · European Journal of Plastic Surgery
The Use of Decision–Analytic Models in Atopic Eczema: A Systematic Review and Critical Appraisal
Emma McManus, Tracey Sach, Nick J. Levell · 2017 · PharmacoEconomics
A cost‐utility analysis comparing CT surveillance, PET‐CT surveillance, and planned postradiation neck dissection for advanced nodal HPV‐positive oropharyngeal cancer
Terence S. Fu, Patrick Scheffler, David W.A. Forner, Christopher W. Noel, Shao Hui Huang, Ralph William Gilbert, David Paul Goldstein, Brian O’Sullivan, Hisham Mohamed Mehanna, John N. Waldron et al. · 2021 · Cancer
Dynamic Transitions of Pediatric Sepsis: A Markov Chain Analysis
Sherry L. Kausch, Jennifer M. Lobo, Michael C. Spaeder, Brynne A. Sullivan, Jessica Keim‐Malpass · 2021 · Frontiers in Pediatrics
Informing radiotherapy decisions in stage I/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry
David A. Jones, Paolo Candio, Rebecca Shakir · 2022 · Blood Advances
Clinical Management and Burden of Prostate Cancer: A Markov Monte Carlo Model
Chiranjeev Sanyal, Armen Garo Aprikian, Fabio Cury · 2014 · PLoS ONE
Cost-effectiveness analysis in the Spanish setting of the PEAK trial of panitumumab plus mFOLFOX6 compared with bevacizumab plus mFOLFOX6 for first-line treatment of patients with wild-type RAS metastatic colorectal cancer
Fernando Rivera, Manuel Valladares, Salvador Gea, Noemí López-Martínez · 2017 · Journal of Medical Economics
Clinical and cost-effectiveness of the Ross procedure versus conventional aortic valve replacement in young adults
Howard H. Z. Thom, Alexandru Ciprian Visan, Edna Keeney · 2019 · Open Heart
Evaluating the Validation Process: Embracing Complexity and Transparency in Health Economic Modelling
Isaac Corro Ramos, Talitha Feenstra, Salah Ghabri · 2024 · PharmacoEconomics
Cost‐Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease
Tzeyu L. Michaud, Jean Marie Abraham, Hawre J. Jalal, Russell V. Luepker, Sue Duval, Alan T. Hirsch · 2015 · Journal of the American Heart Association
Cost-effectiveness of adding Endocuff® to standard colonoscopies for interval colorectal cancer screening
Tiffany M. Yu, Alison Tradonsky, Jun Tang, Renée J.G. Arnold · 2019 · ClinicoEconomics and Outcomes Research
Cost-effectiveness of statin therapy for secondary prevention among patients with coronary artery disease and baseline LDL-C 70–100 mg/dL in Taiwan
Fang‐Ju Lin, Kou‐Gi Shyu, Ching‐Lin Hsieh, Wayne Huey‐Herng Sheu, Shih‐Te Tu, Shoou-Jeng Yeh, Chin-I Chen, Kuo‐Cheng Lu, Chia‐Chao Wu, Wen‐Yi Shau et al. · 2020 · Journal of the Formosan Medical Association
Comparison of Estimated Incentives for Preventing Postpartum Depression in Value-Based Payment Models Using the Net Present Value of Care vs Total Cost of Care
Nathaniel Z. Counts, Margaret R. Kuklinski, Venus W. Wong, Mark Ethan Feinberg, Timothy B. Creedon · 2022 · JAMA Network Open
Economic Evaluations of Guideline-Directed Medical Therapies for Heart Failure With Reduced Ejection Fraction: A Systematic Review
Wai-Chee Kuan, Ruth Sim, Wei Jin Wong, Juman Abdulelah Dujaili, Sazzli Shahlan Kasim, Kenneth Kwing-Chin Lee, Siew Li Teoh · 2023 · Value in Health
Health economic evaluation of single-lead atrial pacing vs. dual-chamber pacing in sick sinus syndrome
Lars Oddershede, Sam Riahi, Jens Cosedis Nielsen, Søren Pihlkjær Hjortshøj, Henning Andersen, Lars Holger Ehlers · 2014 · EP Europace
Economic Evaluation of Nivolumab Plus Ipilimumab Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada
Peter Quon, Ying Xiao, Sonja V. Sorensen · 2019 · PharmacoEconomics - Open
Cost-effectiveness of twice-daily indacaterol/glycopyrrolate inhalation powder for the treatment of moderate to severe COPD in the US
Krithika Rajagopalan, Lisa M. Bloudek, Jessica Marvel, Carole Dembek, Abhishek Kavati · 2018 · International Journal of COPD
Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model
P Wahlqvist, JAY L. WARNER, Robert Morlock · 2018 · Journal of health economics and outcomes research
The Challenges of Parameterizing Direct Effects in Individual-Level Simulation Models
Eleanor J. Murray, James M. Robins, George R. Seage, Kenneth A. Freedberg, Miguel Ángel Hernán · 2020 · Medical Decision Making
A comparison between on-demand usage of rFVIIa vs prophylaxis use of emicizumab in high titer inhibitory hemophilia A patients in Iran
Parisa Saiyarsarai, Atefeh Robabpour Derakhshan, Jamaleddin Khedmati, Peyman Eshghi, Meysam Seyedifar · 2021 · Medicine
Mathematical modelling in tobacco control research: protocol for a systematic review
Shari P. Feirman, Elisabeth A. Donaldson, Jennifer Pearson · 2015 · BMJ Open
Collaborative Modeling: Experience of the U.S. Preventive Services Task Force
Diana B. Petitti, Jennifer S Lin, Douglas K Owens, Jennifer Miller Croswell, Eric J. Feuer · 2017 · American Journal of Preventive Medicine
Cost effectiveness of ixekizumab versus secukinumab in the treatment of moderate-to-severe plaque psoriasis in Spain
Erin Johansson, Mercedes Núñez, Axel Svedbom, Tatiana Dilla, Susanne Hartz · 2018 · ClinicoEconomics and Outcomes Research
A Systematic Literature Review of Modelling Approaches to Evaluate the Cost Effectiveness of PET/CT for Therapy Response Monitoring in Oncology
S. van Mossel, Rafael Emilio de Feria Cardet, L. D. de Geus-Oei, D. Vriens, H. Koffijberg, S. Saing · 2024 · PharmacoEconomics (Auckland)
Evaluation of the Fiscal Costs and Consequences of Alzheimer's Disease in Germany: Microsimulation of Patients' and Caregivers' Pathways
Rui Martins, Nikolaos Kotsopoulos, Bernhard Michalowsky, Peter J. Pemberton-Ross, Michael Urbich, Mark P. Connolly · 2022 · The Journal of Prevention of Alzheimer s Disease
Cost-Effectiveness of Vonoprazan-Based and Rifabutin-Based vs Other Regimens as First-Line Treatment of Helicobacter pylori Infection in the United States
Ismaeel U. Yunusa, Bryan L. Love · 2022 · The American Journal of Gastroenterology
Cost-effectiveness of left atrial appendage closure for stroke prevention in atrial fibrillation: a systematic review appraising the methodological quality
Sumudu Avanthi Hewage, Rini Noviyani, David Brain, Pakhi Sharma, William Anthony Parsonage, Steven McPhail, Adrian Gerard Barnett, Sanjeewa Kularatna · 2023 · Cost Effectiveness and Resource Allocation
Cost-Utility of Gastric Bypass Surgery Compared to Clinical Treatment for Severely Obese With and Without Diabetes in the Perspective of the Brazilian Public Health System
Roberto Pereira Assumpção, Luciana Bahia, Michelle Quarti Machado da Rosa, Marcelo Goulart Correia, Everton Nunes da Silva, Paula Rosales Zubiaurre, Cláudio Corá Mottin, Denizar Araujo Vianna · 2019 · Obesity Surgery
Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK
Bernd Schweikert, Chiara Malmberg, Örjan Åkerborg · 2020 · PharmacoEconomics - Open
Proportional-assist ventilation with load-adjustable gain factors for mechanical ventilation: a cost-utility analysis
Rhodri Saunders, Jason A. Davis, Karen J. Bosma · 2022 · CMAJ Open
The public health benefit and burden of mass drug administration programs in Vietnamese schoolchildren: Impact of mebendazole
Sam Debaveye, Claudia Virginia Gonzalez Torres, Delphine De Smedt, Bert Heirman, Shane Kavanagh, Jo P. Dewulf · 2018 · PLoS neglected tropical diseases
Cost–Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong
Man‐Fung Yuen, Sze-Hang Liu, Wai‐Kay Seto, Lung‐Yi Mak, Shelby L. Corman, Danny Chung Hsu, Mary Y. K. Lee, Tsz Kin Khan, Amy Puenpatom · 2020 · Digestive Diseases and Sciences
Cost-effectiveness of population screening for aortic stenosis
Pouya Motazedian, Graeme Prosperi‐Porta, Benjamin M. Hibbert, Hawre J. Jalal, Marino X. Labinaz, Ian G. Burwash, Omar Abdel‐Razek, Pietro Di Santo, Trevor Simard, George A. Wells et al. · 2024 · European Heart Journal - Quality of Care and Clinical Outcomes
A Systematic Review of Modeling Approaches to Evaluate Treatments for Relapsed Refractory Multiple Myeloma: Critical Review and Considerations for Future Health Economic Models
Andreas P Freitag, Grammati Sarri, An Ta, Laura Gurskyte, Dasha Cherepanov, Luis G. Hernandez · 2024 · PharmacoEconomics
Cost-effectiveness of a machine learning risk prediction model (LungFlag) in the selection of high-risk individuals for non-small cell lung cancer screening in Spain
J. C. Trujillo, J. B. Soriano, M. Marzo, O. Higuera, L. Gorospe, Virginia Pajares, María Eugenia Olmedo, Natalia Arrabal, Andrés Flores, Jose Garcia et al. · 2024 · Journal of Medical Economics
Pharmacological Acromegaly Treatment: Cost-Utility and Value of Information Analysis
Letícia Paula Leonart, Bruno Salgado Riveros, Murray Dale Krahn, Roberto Pontarolo · 2020 · Neuroendocrinology
Modeling obesity in complex food systems: Systematic review
Anita Bhatia, Sergiy M. Smetana, Volker Heinz, Joachim Hertzberg · 2022 · Frontiers in Endocrinology
Early prediction of the impact of public health policies on obesity and lifetime risk of type 2 diabetes: A modelling approach
Pierre Bauvin, Claire Delacôte, Line Carolle Ntandja Wandji · 2024 · PLoS ONE
Cost‐effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosis
Jocelyn Chan, John J. Kim, Brett K. Barrett · 2020 · Journal of Viral Hepatitis
Modeling lifetime costs and health outcomes attributable to secondhand smoke exposure at home among Korean adult women
Jiyae Lee, A Han, Dalwoong Choi, Kyung‐Min Lim, SeungJin Bae · 2017 · BMJ Open
Evaluating Semi-Markov Processes and Other Epidemiological Time-to-Event Models by Computing Disease Sojourn Density as Partial Differential Equations
Joachim Worthington, Eleonora Feletto, Emily He · 2025 · Medical Decision Making
Addressing Missingness in Predictive Models That Use Electronic Health Record Data
Shanshan Lin, Rolf H. H. Groenwold, Hemalkumar B. Mehta, Ji Soo Kim, Jodi B Segal · 2025 · Annals of Internal Medicine
Cost effectiveness of interventions to improve adherence to statin therapy in ASCVD patients in the United States
Shannon O. Armstrong, Richard A Little · 2019 · Patient Preference and Adherence
Cost‐effectiveness of probiotics and fluoride varnish in caries prevention in preschool children
Gonzalo A. Rodriguez, Rodrigo Cabello, Catalina P. Borroni, Raul A. Palacio · 2022 · Journal of Public Health Dentistry
Cost‐effectiveness of Quantitative Pretest Probability Intended to Reduce Unnecessary Medical Radiation Exposure in Emergency Department Patients With Chest Pain and Dyspnea
Jennifer L. Troyer, Alan E. Jones, Nathan Ivan Shapiro, Alice M. Mitchell, Ian Hewer, Jeffrey Allen Kline · 2015 · Academic Emergency Medicine
Cost–effectiveness of denosumab as a bone protective agent for patients with castration resistant prostate cancer
Athanasios Dellis, Athanasios Papatsoris · 2015 · Expert Review of Pharmacoeconomics & Outcomes Research
Cost-effectiveness of Antihypertensive Medication
Gabriel S. Tajeu, Stephen T. Mennemeyer, Nir Menachemi · 2017 · Medical Care
Cost-Effectiveness Analysis of Everolimus versus Mycophenolate in Kidney Transplant Recipients Receiving No Pharmacological Prophylaxis for Cytomegalovirus Infection: A Short-Term Pharmacoeconomic Evaluation (12 Months)
Cláudia Rosso Felipe, Helio Tedesco Silva Junior, Alexandra Nicolau Ferreira Brigido et al. · 2017 · Value in Health Regional Issues
Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women
Paolo Angelo Cortesi, Alessandro Maloberti, Mariangela Micale, Federica Pagliarin, Ippazio Cosimo Antonazzo, Giampiero Mazzaglia, Cristina Giannattasio, Lorenzo Giovanni Mantovani · 2020 · Atherosclerosis
Cost-effectiveness analysis of a strategy to delay progression to dialysis and death among chronic kidney disease patients in Lima, Peru
Enrique M. Saldarriaga, Jessica Bravo-Zúñiga, Yamilée Hurtado-Roca · 2021 · Cost Effectiveness and Resource Allocation
Cost-Effectiveness of Dapagliflozin vs Empagliflozin for Treating Heart Failure With Reduced Ejection Fraction in the United States.
R. Nechi, A. Rane, Rukayyah M. Karaye, C. Ndikumukiza, S. Alsahali, A. Jatau, C. Zoni, A. Alanzi, Ibraheem M. Karaye, Ismaeel Yunusa · 2023 · Clinical Therapeutics
Decision-analytic evaluation of the comparative effectiveness and cost-effectiveness of strategies to prevent breast and ovarian cancer in German women with BRCA-1/2 mutations
Lára R. Hallsson, Gaby Sroczynski, Jutta Engel, Uwe Siebert · 2023 · BMC Cancer
Using Parameter Constraints to Choose State Structures in Cost-Effectiveness Modelling
Howard H. Z. Thom, Christopher H. Jackson, Nicky J. Welton, Linda D. Sharples · 2017 · PharmacoEconomics
Development and validation of a new population-based simulation model of osteoarthritis in New Zealand
Ross Wilson, J. Haxby Abbott · 2018 · Osteoarthritis and Cartilage
Quantifying the handprint—Footprint balance into a single score: The example of pharmaceuticals
Sam Debaveye, Delphine De Smedt, Bert Heirman, Shane Kavanagh, Jo P. Dewulf · 2020 · PLoS ONE
A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence
Philippe Laramée, A. Millier, Thor‐Henrik Brodtkorb, Nora Rahhali, Olivier Cristeau, Samuel Aballéa, Stephen Montgomery, Sara Steeves, Mondher Toumi, Jürgen T. Rehm · 2016 · Clinical Drug Investigation
Decision modelling for economic evaluation of liver transplantation
Zhi Qu, Christian Krauth, Volker Eric Amelung, Alexander Kaltenborn, Jill Gwiasda, Lena Harries, Jan Beneke, Harald Schrem, Sebastian Liersch · 2018 · World Journal of Hepatology
Systematic Review of Economic Evaluations of Cycling Versus Swapping Medications in Patients With Rheumatoid Arthritis After Failure to Respond to Tumor Necrosis Factor Inhibitors
Aliza R. Karpes Matusevich, Maria Eugenia Suarez-Almazor, Scott B. Cantor, Lincy Subha Lal, John Michael Swint, Maria Angeles Lopez-Olivo · 2019 · Arthritis Care & Research
Health Technology Assessment in Epilepsy: Economic Evaluations and Preference Studies
Reina J.A. de Kinderen · 2015 · Research Publications (Maastricht University)
Comparison of partitioned survival modeling with state transition modeling approaches with or without consideration of brain metastasis: a case study of Osimertinib versus pemetrexed-platinum
Y.M. Shim, Byeong-Chan Oh, Eui‐Kyung Lee, Mi-Hai Park · 2024 · BMC Cancer
Cost-effectiveness analysis of mHealth applications for depression in Germany using a Markov cohort simulation
Bettina Freitag, Marie Uncovska, Sven Meister, Christian Prinz, Leonard Fehring · 2024 · npj Digital Medicine
MeDeMSA care study protocol: developing personalized best medical care with integrated mobile palliative and telemedicine support for individuals with multiple system atrophy
Alessandra Fanciulli, Bianca Caliò, Svenja Schmidt, Georg Goebel, Fabian Leys, Karoline Radl, Caroline Breitegger, Marjan Arvandi, Alexa Blum, Christoph Gabl et al. · 2025 · Journal of Neural Transmission
A Systematic Review of the Quality of Economic Models Comparing Thrombosis Inhibitors in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
Maximilian H. M. Hatz, Reiner Leidl, Nichola Yates, Björn Stollenwerk · 2014 · PharmacoEconomics
Cost-effectiveness and health impact of screening and treatment of Mycobacterium tuberculosis infection among formerly incarcerated individuals in Brazil: a Markov modelling study
Ana van Lieshout Titan, Fayette Klaassen, Daniele Maria Pelissari, José Nildo de Barros Silva Júnior, Kleydson Bonfim Andrade Alves, Layana Costa Alves, Mauro Niskier Sanchez, Patrícia Bartholomay, Fernanda Dockhorn Costa Johansen, Júlio Croda et al. · 2024 · The Lancet Global Health
Estimating and Extrapolating Survival Using a State-Transition Modeling Approach: A Practical Application in Multiple Myeloma
Istvan Matyas Majer, Sonja Kroep, Rana Maroun · 2021 · Value in Health
Simulation as an ethical imperative and epistemic responsibility for the implementation of medical guidelines in health care
Luciana Garbayo, James E. Stahl · 2016 · Medicine Health Care and Philosophy
How to measure temporal changes in care pathways for chronic diseases using health care registry data
Eugenio Ventimiglia, Mieke Van Hemelrijck, Lars Lindhagen · 2019 · BMC Medical Informatics and Decision Making
Cost-Effectiveness Analysis of Linagliptin in Japan Based on Results from the Asian Subpopulation in the CARMELINA® Trial
Hirotaka Watada, Hiroyuki Sakamaki, Daisuke Yabe · 2020 · Diabetes Therapy
Quantitative Evidence Synthesis Methods for the Assessment of the Effectiveness of Treatment Sequences for Clinical and Economic Decision Making: A Review and Taxonomy of Simplifying Assumptions
Ruth A. Lewis, Dyfrig Arwyn Hughes, Alex J. Sutton, Clare Wilkinson · 2020 · PharmacoEconomics
Cost-effectiveness analysis of using innovative therapies for the management of moderate-to-severe ulcerative colitis in Spain
Carlos Taxonera, F. de Andrés-Nogales, Santiago García‐López et al. · 2021 · Expert Review of Pharmacoeconomics & Outcomes Research
On an Approach to Evaluation of Health Care Programme by Markov Decision Model
Masayuki Horiguchi · 2021 · Emergence, complexity and computation
Long-term cost-effectiveness of home versus clinic-based management of chronic heart failure: the WHICH? study
Shoko Maru, Joshua Byrnes, Melinda Jane Carrington, Simon Stewart, Paul Scuffham · 2016 · Journal of Medical Economics
OR Applications in Disease Screening
Evrim Didem Güneş, E. Lerzan Örmeci · 2017 · International series in management science/operations research/International series in operations research & management science
Resource utilization in lung cancer diagnostic procedures: Current use and budget consequences
Sander Brinkhof, Harry J.M. Groen, Sabine Siesling · 2017 · PLoS ONE
Cost-Effectiveness of Second-Line Endocrine Therapies in Postmenopausal Women with Hormone Receptor–positive and Human Epidermal Growth Factor Receptor 2–negative Metastatic Breast Cancer in Japan
Verin Lertjanyakun, Nathorn Chaiyakunapruk, Susumu Kunisawa · 2018 · PharmacoEconomics
Challenges in Modelling the Cost Effectiveness of Various Interventions for Cardiovascular Disease
L. Burgers, W. Redekop, J. Severens · 2014 · PharmacoEconomics (Auckland)
Cost-Utility Analysis of a Medication Adherence-Enhancing Educational Intervention for Glaucoma
Anna Hung, Andrew M. Williams, Paula Anne Newman-Casey, Kelly W. Muir, Justin D. Gatwood · 2023 · Ophthalmology Glaucoma
Cost-effectiveness of endovascular treatment after 6–24 h in ischaemic stroke patients with collateral flow on CT-angiography: A model-based economic evaluation of the MR CLEAN-LATE trial
Florentina M.E. Pinckaers, Silvia Evers, Susanne G. H. Olthuis · 2023 · European Stroke Journal
Different Models, Same Results: Considerations When Choosing Between Approaches to Model Cost Effectiveness of Chimeric-Antigen Receptor T-Cell Therapy Versus Standard of Care
Amy Gye, Richard De Abreu Lourenço, Stephen Goodall · 2024 · PharmacoEconomics
Real-world cost-effectiveness analysis of thymoglobulin versus no induction therapy in kidney transplant recipients at low risk of graft loss
Adrieli Barros Bessa, Marina Pontello Cristelli, Cláudia Rosso Felipe · 2024 · Brazilian Journal of Nephrology
Differential impact of test performance characteristics on burden-to-benefit tradeoffs for blood-based colorectal cancer screening: A microsimulation analysis
Andrew J. Piscitello, Lauren N. Carroll, Signe Fransen, Ben Wilson, Tarun Chandra, Reinier G.S. Meester, Girish V. Putcha · 2023 · Journal of Medical Screening
Comparative value of dapagliflozin vs empagliflozin in patients with heart failure and preserved ejection fraction: A cost-effectiveness analysis
Amey Rane, Regina Nwamaka Nechi, Maryam Imam, Rodrigo Zoni, Cyrille Ndikumukiza, Ibraheem M. Karaye, Ismaeel U. Yunusa, Abdullah Alanzi · 2023 · Journal of Managed Care & Specialty Pharmacy
Models of evaluation under ceteris imparibus: System dynamics and the example of emergency care
Sue McAvoy, Andrew N Staib, Stephen Birch · 2019 · Systems Research and Behavioral Science
Evidence‐Based Medicine in Otolaryngology, Part XI: Modeling and Analysis to Support Decisions
Lisa Caulley, M. G. Myriam Hunink, Gregory William Randolph, Jennifer Joan Shin · 2020 · Otolaryngology
Cost-utility analysis of medication review with follow-up for cardiovascular outcomes: A microsimulation model
Antonio Ahumada‐Canale, Constanza Vargas, Francisco Martínez‐Mardones · 2021 · Health Policy
Cost Utility of Bronchial Thermoplasty for Severe Asthma: Implications for Future Cost-Effectiveness Analyses Based on Phenotypic Heterogeneity
Jessica Keim‐Malpass, Howard Charles Malpass · 2022 · ClinicoEconomics and Outcomes Research
Building a Microsimulation Model of Heroin Use Careers in Australia
Alison J. Ritter, Nagesh Shukla, Marian Shanahan, Phuong Van Hoang, Vu Lam Cao, Pascal Perez, Michael Farrell · 2015
A systematic review of the methodological quality of economic studies evaluating ophthalmic drugs
Inês Ribeiro, Francisco Batel Marques, Dalila Gil Alves, Carlos Alves · 2019 · Expert Review of Pharmacoeconomics & Outcomes Research
Population-Level Health Benefits and Harms Associated With Buprenorphine/Naloxone vs Methadone
Benjamin Enns, Brenda Carolina Guerra‐Alejos, Jeong Eun Min, Addie Carter, Uwe Siebert, Bohdan Nosyk · 2025 · JAMA Network Open